Scientists Develop Early Alzheimer’s Detection Test – Years Before Symptoms Appear
A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...
The Lancet2d
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority
More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...
Hosted on MSN3d
Novel Antibody Platform Targets Aggregates in Alzheimer's and Parkinson's
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...
Peristaltic pump flow: A potential trigger for amyloid protein aggregation
The factor that tips you over the edge from being at risk for a disease to actually developing the disease is not always clear. Now, researchers from Japan report one factor that triggers problematic ...
Novel antibody discovery platform may inform Alzheimer's and Parkinson's research
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...
Could We Be Fighting Alzheimer’s Wrong? New Research Suggests a Different Approach
Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.
Armed robbery in Revesby6d
New Antibody Platform Aids Alzheimers, Parkinsons
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...